3 years ago

Identification of essential genes for cancer immunotherapy

Identification of essential genes for cancer immunotherapy
Arash Eidizadeh, Anna Chichura, Eric Tran, Jared J. Gartner, Chi-Ping Day, Neville E. Sanjana, Feng Zhang, Madhusudhanan Sukumar, Seth M. Steinberg, Li Jia, Suman K. Vodnala, Rigel J. Kishton, Nicholas P. Restifo, Paul Robbins, Maggie Cam, Glenn Merlino, Steve Feldman, Robert Eil, Shashank J. Patel, Ophir Shalem, Gautam U. Mehta, Anand S. Merchant, Tori N. Yamamoto, Eva Perez Guijarro
Somatic gene mutations can alter the vulnerability of cancer cells to T-cell-based immunotherapies. Here we perturbed genes in human melanoma cells to mimic loss-of-function mutations involved in resistance to these therapies, by using a genome-scale CRISPR–Cas9 library that consisted of around 123,000 single-guide RNAs, and profiled genes whose loss in tumour cells impaired the effector function of CD8+ T cells. The genes that were most enriched in the screen have key roles in antigen presentation and interferon-γ signalling, and correlate with cytolytic activity in patient tumours from The Cancer Genome Atlas. Among the genes validated using different cancer cell lines and antigens, we identified multiple loss-of-function mutations in APLNR, encoding the apelin receptor, in patient tumours that were refractory to immunotherapy. We show that APLNR interacts with JAK1, modulating interferon-γ responses in tumours, and that its functional loss reduces the efficacy of adoptive cell transfer and checkpoint blockade immunotherapies in mouse models. Our results link the loss of essential genes for the effector function of CD8+ T cells with the resistance or non-responsiveness of cancer to immunotherapies.

Publisher URL: http://dx.doi.org/10.1038/nature23477

DOI: 10.1038/nature23477

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.